PROTACs: New method to degrade transcription regulating proteins

Area of Science:

• Molecular Biology
• Biochemistry
• Drug Discovery

Background:

• Transcription is a fundamental biological process involving numerous proteins, whose overexpression can lead to various diseases.
• Current therapeutic inhibitors for transcription regulation show limited efficacy.
• There is a need for advanced technologies to improve therapeutic outcomes for transcription-related diseases.

Purpose of the Study:

• To review the emerging role of Proteolysis-Targeting Chimeras (PROTACs) in regulating transcription.
• To highlight the advantages of PROTACs over traditional inhibitors for diseases driven by protein overexpression.
• To summarize current PROTAC applications in disease treatment and biological research.

Main Methods:

• Literature review of PROTAC technology.
• Analysis of PROTACs targeting transcription regulators.
• Discussion of PROTAC mechanisms and applications.

Main Results:

• PROTACs are bifunctional molecules that induce target protein ubiquitination and proteasomal degradation.
• PROTACs demonstrate superior efficiency in degrading overexpressed transcription regulators compared to inhibitors.
• The review summarizes 29 PROTACs targeting transcription regulators, detailing their advantages.

Conclusions:

• PROTACs represent a promising therapeutic modality for diseases linked to transcription dysregulation.
• PROTACs offer enhanced efficacy for degrading target proteins, addressing limitations of conventional therapies.
• PROTACs serve as valuable tools for both disease treatment and fundamental biological research in transcription.